The FDA approved a proximal hypoglossal nerve stimulation device (aura6000 system) for adults with moderate to severe obstructive sleep apnea (OSA), maker LivaNova announced on Thursday. FDA's ...
LivaNova's aura6000 system delivers synchronised electrical pulses to the hypoglossal nerve to prevent airways collapse in ...
Hypoglossal nerve stimulation therapy approved in the U.S. without complete concentric collapse contraindication or warning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results